Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)

American Journal of Cardiology

Volumn 78, Issue 1, 1996, Pages 61-65

  Devereux, Richard B ^a   Dahlöf, Björn ^b   Levy, Daniel ^b   Pfeffer, Marc A ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; NIFEDIPINE;

ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 0030200916     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00228-7     Document Type: Article

References (29)

1. 1. Devereux RB, Alderman MH. The role of preclinical cardiovascular disease in the evolution from risk factor exposure to the development of clinical morbid events. Circulation 1993;88:1444-1455.
2. 2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
3. 3. Mensah GA, Pappas TW, Koren MJ, Ulin RJ, Laragh JH, Devereux RB. Comparison of classification of hypertension severity by blood pressure level and World Health Organization criteria for prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension. J Hypertension 1993;11:1429-1440.
4. 4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically-determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
5. 5. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, Castelli WP. Left ventricular mass and the risk of stroke in an elderly cohort: The Framingham Study. JAMA 1994;272:33-36.
6. 6. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992;117:831-836.
7. 7. Bolognese L, Dellavesa P, Rossi L, Sarasso G, Bongo AS, Scianaro MC. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 1994;73:1-5.
8. 8. Devereux RB. Angiotensin converting enzyme inhibition and regression of hypertensive left ventricular hypertrophy. In: MacGregor GA, Sever PS, eds. Current Advances in ACE Inhibition, 2. Edinburgh; Churchill Livingston, 1991;43-52.
9. 9. Dahlöf B, Pennert K, Hannson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
10. 10. Cruickshank J, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.
11. 11. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Black JM, Schoenberger JA, McDonald R, Lewis CE, Liebson PR, for the Treatment of Mild Hypertension Research Group. Treatment of Mild Hypertension Study: final results. JAMA 1993;270:713-724.
12. 12. Gottdiener JS, Reda D, Notargiacomo A, Materson B. Comparison of monotherapy on LV mass regression in mild-to-moderate hypertension: results of a multicenter trial (abstr). J Am Coll Cardiol 1991;17:178A.
13. 13. Gottdiener JS, Reda D, Notargiacomo A, Materson B. Comparison of monotherapy effects on LV mass regression in mild-to-moderate hypertension: differences between short and long-term therapy. J Am Coll Cardiol 1992;19:85. Abstract.
14. 14. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 1990;86:1913-1920.
15. 15. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
16. 16. Bielen EC, Fagard RH, Lijnen PJ, Tjandra-Maga TB, Verbesselt R, Amery A. Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension. Am J Cardiol 1992;69:1200-1206.
17. 17. Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens 1990;3:512-517.
18. 18. Devereux RB, Dahlof B. Criteria for an informative trial of left ventricular hypertrophy regression. J Hum Hypertens 1994;8:735-739.
19. 19. Devereux RB, Roman MJ. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques. In Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, Treatment. New York: Raven Press, 1995:1969-1985.
20. 20. Gardner MJ, Heady JA. Some effects of within-person variability in epidemiological studies. J Chron Disease 1973;26:781-795.
21. 21. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
22. 22. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux RB, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiography 1989;2:358-367.
23. 23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
24. 24. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH. Assessment of left ventricular function by the mid-wall fractional shortening-end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994;23:1444-1451.
25. 25. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990;120:116-123.
26. 26. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer electrocardiogram interpretation: necropsy validation. Circulation 1987;75:565-572.
27. 27. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992;20:1180-1186.
28. 28. Norman JE, Levy D, Campbell G, Bailey JJ. Improved detection of echocardiographic left ventricular hypertrophy using a new electrocardiographic algorithm. J Am Coll Cardiol 1993;21:1680-1686.
29. 29. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995;25:417-423.